France In-Vitro Diagnostics (IVD) Market by Segments, Types (Laboratory Reagents, Instruments), & Companies
In Vitro Diagnostic services are done either through imaging like scanning, radiology, and ultrasound or in laboratories via pathology, IVD plays a crucial function in identifying health-related problems. In Vitro Diagnostic comes under medical device segment in France, which is utilized for disease diagnostic and medical treatment. Timely diagnosis improves the chances of positive development, thus helping in saving the costs of future treatment and improving the lives of patients. Moreover In Vitro Diagnostics also plays an important part in ongoing care program for patients. As per Renub Research report France In Vitro Diagnostics market is expected to be around US$ 5 Billion by the end of the year 2024.
Currently, the United States dominates the In Vitro diagnostics market followed by Europe. This particular trend is also expected to continue in the future. Growth in the number of an aging population has become one of the important drivers for the In vitro diagnostics market in France. In 1991, EU-28’s population, of persons aged 65and over was 13.9% and this figure further increased to 18.5% by the end of the year 2014. In Europe, most medical technologies are reimbursed by Public Health Authorities, generally within a third-party payer system. However, each European country has its own special nature; in a few European countries reimbursement and budgeting is decided at the regional level, whereas in some countries it is decided by the national government of that country.
Renub Research report titled “France In-Vitro Diagnostics (IVD) Market by Segments (Immunochemistry, Hematology, Infectious Immunology, Microbiology, Bio-chemistry, Genetic Testing), Types (Laboratory Reagents, Instruments), Companies (Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Sysmex Corporation)” provides a complete analysis of France In-Vitro Diagnostics (IVD) market.
Laboratory reagents is the leading products in the France In-Vitro Diagnostics (IVD) Market
In this report, we have done comprehensive analysis of France In-Vitro Diagnostics (IVD) market by products. It includes laboratory reagents and instruments market. The laboratory reagent is the leading segment in the France In-Vitro Diagnostics (IVD) market.
Immunochemistry dominates the France IVD Market
France In-Vitro Diagnostics (IVD) Market is segmented into immunochemistry, hematology, infectious immunology, microbiology, bio-chemistry and genetic testing. Immunochemistry has the highest market in the France IVD segment.
Company Analysis
Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Sysmex Corporation are some of the top companies in the France In-Vitro Diagnostics (IVD) Market. All the companies have been studied from three points
Currently, the United States dominates the In Vitro diagnostics market followed by Europe. This particular trend is also expected to continue in the future. Growth in the number of an aging population has become one of the important drivers for the In vitro diagnostics market in France. In 1991, EU-28’s population, of persons aged 65and over was 13.9% and this figure further increased to 18.5% by the end of the year 2014. In Europe, most medical technologies are reimbursed by Public Health Authorities, generally within a third-party payer system. However, each European country has its own special nature; in a few European countries reimbursement and budgeting is decided at the regional level, whereas in some countries it is decided by the national government of that country.
Renub Research report titled “France In-Vitro Diagnostics (IVD) Market by Segments (Immunochemistry, Hematology, Infectious Immunology, Microbiology, Bio-chemistry, Genetic Testing), Types (Laboratory Reagents, Instruments), Companies (Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Sysmex Corporation)” provides a complete analysis of France In-Vitro Diagnostics (IVD) market.
Laboratory reagents is the leading products in the France In-Vitro Diagnostics (IVD) Market
In this report, we have done comprehensive analysis of France In-Vitro Diagnostics (IVD) market by products. It includes laboratory reagents and instruments market. The laboratory reagent is the leading segment in the France In-Vitro Diagnostics (IVD) market.
Immunochemistry dominates the France IVD Market
France In-Vitro Diagnostics (IVD) Market is segmented into immunochemistry, hematology, infectious immunology, microbiology, bio-chemistry and genetic testing. Immunochemistry has the highest market in the France IVD segment.
Company Analysis
Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Sysmex Corporation are some of the top companies in the France In-Vitro Diagnostics (IVD) Market. All the companies have been studied from three points
- Overview
- Initiatives & Recent Developments
- Sales
- Laboratory Reagents
- Instruments
- Immunochemistry
- Hematology
- Infectious Immunology
- Microbiology
- Bio-chemistry
- Genetic Testing
- Roche Diagnostics
- Abbott Diagnostics
- Siemens Healthineers
- Danaher Corporation
- Thermo Fisher Scientific
- Sysmex Corporation
1. INTRODUCTION
2. RESEARCH & METHODOLOGY
3. FRANCE IN-VITRO DIAGNOSTICS (IVD) MARKET
4. MARKET SHARE – FRANCE IN-VITRO DIAGNOSTICS (IVD)
4.1 By Types
4.2 By Segments
5. TYPES – FRANCE IN-VITRO DIAGNOSTICS (IVD) MARKET
5.1 Laboratory Reagents
5.2 Instruments
6. SEGMENTS – FRANCE IN-VITRO DIAGNOSTICS (IVD) MARKET
6.1 Immunochemistry
6.2 Hematology
6.3 Infectious Immunology
6.4 Microbiology
6.5 Bio-chemistry
6.6 Genetic Testing
7. GOVERNMENT RULES & REGULATION
8. REIMBURSEMENT
8.1 Public
8.2 Private & Insurance
9. MARKET DYNAMICS
9.1 Growth Drivers
9.1.1 Increase in the Cancer Disease Population
9.1.2 Technological Advances
9.1.3 Rapidly Aging Population
9.2 Challenges
9.2.1 Cumbersome Reimbursement Procedure
10. COMPANY ANALYSIS
10.1 Roche Diagnostics
10.2 Abbott Diagnostics
10.3 Siemens Healthineers
10.4 Danaher Corporation
10.5 Thermo Fisher Scientific
10.6 Sysmex Corporation
Lists of Figures:
Figure-01: France IVD Market (Million US$), 2014 – 2018
Figure-02: Forecast for France IVD Market (Million US$), 2019 – 2024
Figure-03: France In-Vitro Diagnostics (IVD) Market Share (%) by Types, 2014 – 2018
Figure-04: Forecast for France IVD Market Share (%) by Segments, 2019 – 2024
Figure-05: France In-Vitro Diagnostics (IVD) Market Share (%) by Products, 2014 – 2018
Figure-06: Forecast for France IVD Market Share (%) by Products, 2019 – 2024
Figure-07: France In Vitro Diagnostic Market by Laboratory Reagents (Million US$), 2014-2018
Figure-08: France - Forecast for IVD Market by Laboratory Reagents (Million US$), 2019 - 2024
Figure-09: Alcohol Per Capita (15+) Consumption (in Liters of pure Alcohol)
Figure-10: France In Vitro Diagnostic Market by Instruments (Million US$), 2014-2018
Figure-11: France - Forecast for IVD Market by Instruments (Million US$), 2019 - 2024
Figure-12: France – In-Vitro Diagnostics Market by Immunochemistry (Million US$), 2014 – 2018
Figure-13: France – Forecast for IVD Market by Immunochemistry (Million US$), 2019 – 2024
Figure-14: France – In-Vitro Diagnostics Market by Hematology (Million US$), 2014 – 2018
Figure-15: France – Forecast for IVD Market by Hematology (Million US$), 2019 – 2024
Figure-16: France – In-Vitro Diagnostics Market by Infectious Immunology (Million US$), 2014 – 2018
Figure-17: France – Forecast for IVD Market by Infectious Immunology (Million US$), 2019 – 2024
Figure-18: France – In-Vitro Diagnostics Market by Microbiology (Million US$), 2014 – 2018
Figure-19: France – Forecast for IVD Market by Microbiology (Million US$), 2019 – 2024
Figure-20: France – In-Vitro Diagnostics Market by Bio-chemistry (Million US$), 2014 – 2018
Figure-21: France – Forecast for IVD Market by Bio-chemistry (Million US$), 2019 – 2024
Figure-22: France – In-Vitro Diagnostics Market by Genetic Testing (Million US$), 2014 – 2018
Figure-23: France – Forecast for IVD Market by Genetic Testing (Million US$), 2019 – 2024
Figure-24: Major EU Countries Cancer Rates
Figure-25: Roche Diagnostics – Global Sales (Million US$), 2014 – 2018
Figure-26: Roche Diagnostics – Global Sales Forecast (Million US$), 2019 – 2024
Figure-27: Abbott Diagnostics – Global Sales (Million US$), 2014 – 2018
Figure-28: Abbott Diagnostics – Global Sales Forecast (Million US$), 2019 – 2024
Figure-29: Siemens Healthineers – Global Diagnostics Sales (Million US$), 2015 – 2018
Figure-30: Siemens Healthineers – Global Diagnostics Sales Forecast (Million US$), 2019 – 2024
Figure-31: Danaher Corporation – Global Diagnostics Sales (Million US$), 2014 – 2018
Figure-32: Danaher Corporation – Global Diagnostics Sales Forecast (Million US$), 2019 – 2024
Figure-33: Thermo Fisher Scientific – Global Diagnostics Sales (Million US$), 2014 – 2018
Figure-34: Thermo Fisher Scientific – Global Diagnostics Sales Forecast (Million US$), 2019 – 2024
Figure-35: Sysmex Corporation – Global Diagnostics Sales (Million US$), 2014 – 2018
Figure-36: Sysmex Corporation – Global Diagnostics Sales Forecast (Million US$), 2019 – 2024
2. RESEARCH & METHODOLOGY
3. FRANCE IN-VITRO DIAGNOSTICS (IVD) MARKET
4. MARKET SHARE – FRANCE IN-VITRO DIAGNOSTICS (IVD)
4.1 By Types
4.2 By Segments
5. TYPES – FRANCE IN-VITRO DIAGNOSTICS (IVD) MARKET
5.1 Laboratory Reagents
5.2 Instruments
6. SEGMENTS – FRANCE IN-VITRO DIAGNOSTICS (IVD) MARKET
6.1 Immunochemistry
6.2 Hematology
6.3 Infectious Immunology
6.4 Microbiology
6.5 Bio-chemistry
6.6 Genetic Testing
7. GOVERNMENT RULES & REGULATION
8. REIMBURSEMENT
8.1 Public
8.2 Private & Insurance
9. MARKET DYNAMICS
9.1 Growth Drivers
9.1.1 Increase in the Cancer Disease Population
9.1.2 Technological Advances
9.1.3 Rapidly Aging Population
9.2 Challenges
9.2.1 Cumbersome Reimbursement Procedure
10. COMPANY ANALYSIS
10.1 Roche Diagnostics
10.2 Abbott Diagnostics
10.3 Siemens Healthineers
10.4 Danaher Corporation
10.5 Thermo Fisher Scientific
10.6 Sysmex Corporation
Lists of Figures:
Figure-01: France IVD Market (Million US$), 2014 – 2018
Figure-02: Forecast for France IVD Market (Million US$), 2019 – 2024
Figure-03: France In-Vitro Diagnostics (IVD) Market Share (%) by Types, 2014 – 2018
Figure-04: Forecast for France IVD Market Share (%) by Segments, 2019 – 2024
Figure-05: France In-Vitro Diagnostics (IVD) Market Share (%) by Products, 2014 – 2018
Figure-06: Forecast for France IVD Market Share (%) by Products, 2019 – 2024
Figure-07: France In Vitro Diagnostic Market by Laboratory Reagents (Million US$), 2014-2018
Figure-08: France - Forecast for IVD Market by Laboratory Reagents (Million US$), 2019 - 2024
Figure-09: Alcohol Per Capita (15+) Consumption (in Liters of pure Alcohol)
Figure-10: France In Vitro Diagnostic Market by Instruments (Million US$), 2014-2018
Figure-11: France - Forecast for IVD Market by Instruments (Million US$), 2019 - 2024
Figure-12: France – In-Vitro Diagnostics Market by Immunochemistry (Million US$), 2014 – 2018
Figure-13: France – Forecast for IVD Market by Immunochemistry (Million US$), 2019 – 2024
Figure-14: France – In-Vitro Diagnostics Market by Hematology (Million US$), 2014 – 2018
Figure-15: France – Forecast for IVD Market by Hematology (Million US$), 2019 – 2024
Figure-16: France – In-Vitro Diagnostics Market by Infectious Immunology (Million US$), 2014 – 2018
Figure-17: France – Forecast for IVD Market by Infectious Immunology (Million US$), 2019 – 2024
Figure-18: France – In-Vitro Diagnostics Market by Microbiology (Million US$), 2014 – 2018
Figure-19: France – Forecast for IVD Market by Microbiology (Million US$), 2019 – 2024
Figure-20: France – In-Vitro Diagnostics Market by Bio-chemistry (Million US$), 2014 – 2018
Figure-21: France – Forecast for IVD Market by Bio-chemistry (Million US$), 2019 – 2024
Figure-22: France – In-Vitro Diagnostics Market by Genetic Testing (Million US$), 2014 – 2018
Figure-23: France – Forecast for IVD Market by Genetic Testing (Million US$), 2019 – 2024
Figure-24: Major EU Countries Cancer Rates
Figure-25: Roche Diagnostics – Global Sales (Million US$), 2014 – 2018
Figure-26: Roche Diagnostics – Global Sales Forecast (Million US$), 2019 – 2024
Figure-27: Abbott Diagnostics – Global Sales (Million US$), 2014 – 2018
Figure-28: Abbott Diagnostics – Global Sales Forecast (Million US$), 2019 – 2024
Figure-29: Siemens Healthineers – Global Diagnostics Sales (Million US$), 2015 – 2018
Figure-30: Siemens Healthineers – Global Diagnostics Sales Forecast (Million US$), 2019 – 2024
Figure-31: Danaher Corporation – Global Diagnostics Sales (Million US$), 2014 – 2018
Figure-32: Danaher Corporation – Global Diagnostics Sales Forecast (Million US$), 2019 – 2024
Figure-33: Thermo Fisher Scientific – Global Diagnostics Sales (Million US$), 2014 – 2018
Figure-34: Thermo Fisher Scientific – Global Diagnostics Sales Forecast (Million US$), 2019 – 2024
Figure-35: Sysmex Corporation – Global Diagnostics Sales (Million US$), 2014 – 2018
Figure-36: Sysmex Corporation – Global Diagnostics Sales Forecast (Million US$), 2019 – 2024
